PortalRankings.com
 

Websites linking back to hcpfirst.com

5 websites are linking back to hcpfirst.com in their content.

 
Total results: 5
Domains on this page: 5
 

Results:

Relapsing-remitting MS Treatment – Gilenya (fingolimod)
http://portalrankings.com/info/gilenyahcp.com
Learn more about Gilenya, a sphingosine 1-phosphate receptor modulator indicated for the treatment of patients with relapsing-remitting MS. See ISI for details.
  • Updated On (Date): 2017-Apr-17
  • Expiration time: 2019-May-18
  • Website Registered On (Date): 2015-May-18
IL-17A Antagonist for PsO, PsA, & AS - COSENTYX (secukinumab)
http://portalrankings.com/info/cosentyxhcp.com
Learn about COSENTYX (secukinumab), the first fully human IL-17A antagonist approved for plaque psoriasis, psoriatic arthritis, andankylosing spondylitis.
  • Updated On (Date): 2017-Apr-17
  • Expiration time: 2019-May-18
  • Website Registered On (Date): 2015-May-18
Multiple Sclerosis Treatment | EXTAVIA
http://portalrankings.com/info/extaviahcp.com
EXTAVIA is a disease-modifying therapy (DMT) for people with relapsing forms of multiple sclerosis (MS). Learn about multiple sclerosis treatment and therapy.
  • Updated On (Date): 2017-Apr-17
  • Expiration time: 2019-May-18
  • Website Registered On (Date): 2015-May-18
Chronic Heart Failure (HFrEF) Treatment – ENTRESTO (sacubitril/valsartan) tablets
http://portalrankings.com/info/entrestohcp.com
Learn about ENTRESTO (sacubitril/valsartan), the HFrEF treatment for patients with chronic heart failure (NYHA Class II–IV) and reduced ejection fraction.
  • Updated On (Date): 2017-Apr-06
  • Expiration time: 2019-May-07
  • Website Registered On (Date): 2015-May-07
HCP First by Novartis Pharmaceuticals Corporation
http://portalrankings.com/info/hcpfirst.com
Welcome to HCP First, a resource from Novartis that allows HCPs to learn about medications, find office & patient support, and gain access to professional materials.
  • Updated On (Date): 2017-May-20
  • Expiration time: 2019-Jun-20
  • Website Registered On (Date): 2015-Jun-20
2024-05-05 00:15:09 || 0.0078